Shares of CPSI (NASDAQ:CPSI) were flat in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were up 92.31% over the past year to $0.75, which beat the estimate of $0.55.
CPSI (NASDAQ:CPSI) reported quarterly earnings of $0.75 per share which beat the analyst consensus estimate of $0.55 by 36.36 percent. This is a 92.31 percent increase over earnings of $0.39 per share from the same
Companies Reporting Before The Bell
• Myriad Genetics (NASDAQ:MYGN) is likely to report earnings for its fourth quarter.
• Stellantis (NYSE:STLA) is expected to report earnings for its second quarter.
CPSI (NASDAQ:CPSI), a healthcare solutions company, and Medicomp Systems, which makes medical data relevant, usable and actionable, today announced that CPSI is integrating Medicomp's Quippe Clinical Data Engine
CPSI (NASDAQ:CPSI) showed a loss in earnings since Q4, totaling $4.91 million. Sales, on the other hand, increased by 1.73% to $68.00 million during Q1. In Q4, CPSI earned $5.97 million and total sales reached $66.85 million.
CPSI (NASDAQ:CPSI) posted a 17.73% decrease in earnings from Q4. Sales, however, increased by 1.73% over the previous quarter to $68.00 million. Despite the increase in sales this quarter, the decrease in earnings may suggest CPSI is not utilizing their capital as effectively as possible.
Companies Reporting Before The Bell
• Revlon (NYSE:REV) is likely to report earnings for its first quarter.
• Bluegreen Vacations (NYSE:BVH) is expected to report earnings for its first quarter.